Are you Health Professional?
Register now, join the community for free access.
GET ALL THE BENEFITS THAT MEDTUBE PLATFORM OFFERS:
- Unlimited access to the largest e-library of professional videos, images, publications, courses
- Connect with peers 450,000+ Healthcare Professionals from 180 countries
- Upload and share your own cases, ask questions and discuss
- Create your professional profile and build personal recognition worldwide
- Stay up-to-date with innovative techniques, treatments, guidelines, discoveries in your fields of interest; be notified
- You are informed about innovative treatments, techniques and innovations in medicine
DELIVER Results - Scott D. Solomon, MD
Case description
Investigator Scott D. Solomon, MD recaps the results of the DELIVER trial, which found that among individuals with heart failure and a mildly reduced or preserved ejection fraction, dapagliflozin reduced the combined risk of worsening heart failure or cardiovascular death.
This user also sharing
Understanding Hyperthyroidism and Graves Dise...
views: 3134
What causes Cushings Syndrome?
views: 2403
Postpartum thyroiditis - causes, symptoms, di...
views: 2333
Cushing Syndrome - causes, symptoms, diagnosi...
views: 2898
Primary adrenal insufficiency (Addison's dise...
views: 2791
Recommended
Cleft Anterior Leaflet of MV
Mohammed Zidan
views: 159
